Efficacy of combined administration of an alginate formulation («gaviscon») and lansoprazole for children with gastroesophageal reflux disease

Italian Journal of Pediatrics

Volumn 28, Issue 4, 2002, Pages 304-309

  Borrelli, O ^a   Rea, P ^a   Bueno de Mesquita, M ^a   Ambrosini, A ^a   Mancini, V ^a   Di Nardo, G ^a   Cucchiara, Salvatore ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antacids; Esophagitis; Gastric secretion; Gastroesophageal reflux; Proton pump inhibitors

Indexed keywords

GAVISCON; LANSOPRAZOLE;

ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENDOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; INTERMETHOD COMPARISON; MALE; PH MEASUREMENT; SCORING SYSTEM; STOMACH MUCOSA; STOMACH PH; TREATMENT OUTCOME;

EID: 0036704943     PISSN: 17208424     EISSN: 18247288     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hillemeier AC. Gastroesophageal reflux. Diagnostic and therapeutic approaches. Ped Clin North Am 1996;43:197-212.
2. Cucchiara S, Bortolotti M, Minella R, Auricchio S. Fasting and postprandial mechanisms of gastroesophageal reflux in children with gastroesophageal reflux disease. Dig Dis Sci 1993;38:86-92.
3. Rudolph CD, Mazur LJ, Liptak GS, Baker RD, Boyle JT, Colletti RB, et al. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 2001;32(Suppl 2):S1-S31.
4. Poynard T. Relapse rate of patients after healing of oesophagitisa prospective study of arginate as self-care treatment for 6 months. Aliment Pharmacol Ther 1993;7:385-92.
5. Chevrel B. A comparative crossover study on the treatment of heartburn and epigastric pain: liquid Gaviscon and a magnesium-aluminum antacid gel. J Int Med Res 1980;8:300-2.
6. Mandel KG, Daggy BP, Brodie DA, Jacoby HI. Review article: alginate-raft formulation in the treatment of heartburn and acid reflux. Aliment Pharmacol Ther 2000;14:669-90.
7. Johnson FA, Craug DQM, Mercer AD, Chauhan S. The effects of alginate molecular structure and formulation variables on the physical characteristics of alginate raft systems. Int J Pharmaceut 1997;159:35-42.
8. Buts JP, Bardi C, Otte JB. Double-bind controlled study on the efficacy of sodiumalginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24-h continuous pH monitoring in infants and children. Eur J Pediatr 1987;146:156-8.
9. Greally P, Hampton FJ, MacFadyen UM, Simpson H. Gaviscon and Carobel compared with cisapride in gastro-oesophageal reflux. Arch Dis Child 1992;67:618-21.
10. Miller S. Comparison of the efficacy and safety of a new aluminium-free paediatric alginate preparation and placebo in infants with recurrent gastro-oesophageal reflux. Curr Med Res Opin 1999;15:160-8.
11. Franco MT, Salvia G, Spadaro R, De Rosa I, Iula VD, Cucchiara S. Lansoprazole in the treatment of gastro-oesophageal reflux in childhood. Dig Liver Dis 2000;32:660-6.
12. Working group of the European Society of Pediatric Gastroenterology and Nutrition. A standardized protocol for the methodology of oesophageal pH monitoring and interpretation of the data for the diagnosis of gastroesophageal reflux. J Pediatr Gastroenterol Nutr 1992;14:467-71.
13. Hetzel DJ, Dent J, Reed WD, Norielvada FM, Macknnon MJ, McCarthy, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988;94:81-90.
14. Gunasekaran TS, Hassal EG. Efficacy and safety of omeprazole for severe gastroesophageal reflux in children. J Pediatr 1993;123:148-54.
15. Weldon AP, Robinson MJ. Trial of gaviscon in the treatment of gastro-oesophageal reflux in infancy. Aust Paediatr J 1972;8:279-81.
16. Le Luyer B, Muogenot JF, Mashako, Chapoy P, Olives JP, Morali A, et al. Milticenter study of sodium alginate in the treatment of regurgitation in infants. Ann Pediatr (Paris) 1992;39:635-40.
17. Orenstein SR. Controversies in pediatric gastroesophageal reflux. J Pediatr Gastroenterol Nutr 1992;14:338-48.
18. DeVault KR, Achem SR. Functional gastroesophageal reflux disease. Curr Trea Options Gastroenterol 2000;4:295-302.
19. Hassal E, Israel D, Shepard R, Radke M, Dalvag A, Skold B, et al. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, tolerability and dose requirement. International Pediatric Omeprazole study group. J Pediatr 2000;137:800-7.
20. Oderda G, Dell'Olio D, Forni M, Farina L, Tavassoli K, Ansaldi N. Treatment of childhood peptic oesophagitis with famotidine or alginate-antacid. Ital J Gastroenterol 1990;22:346-9.
21. Goves J, Oldring JK, Kerr D, Dallara RG, Roffe EJ, Powel JA, et al. First line treatment with omeprazole provides an effective and superior alternative strategy in the management of dyspepsia compared to antacid/alginate liquid: a multicentre study in general practice. Aliment Pharmacol Ther 1998;12:147-57.
22. Washington N, Sykes J, Steele RJC, Parker MA, Tierney G, Washington C, et al. Time of onset of action of sodium alginate, ranitidine, omeprazole and water based on oesophageal pH. Gastroenterol 1999;116:A350.